SAN FRANCISCO -- A new commercially available test called T-Detect has received emergency use authorization from the FDA. The manufacturer says it has the power to tell most patients whether or not ...
There's another theory about the Covid-19 pandemic going around, and while it is pretty cool, it's not exactly the solution ...
New research shows that after the body's defenses kill the virus behind COVID-19, leftover digested chunks of SARS-CoV-2 ...
Discover how UCSF is leading the charge in Long COVID research, uncovering key findings that advance our understanding of the ...
A detailed analysis of immune cells in Long COVID patients has revealed a previously unknown molecular signature linked to lingering symptoms. In Germany, Long COVID develops in up to about one in ten ...
Contrary to public concerns, receiving frequent COVID-19 booster vaccinations will not weaken the immune system, providing reassurance to vulnerable groups facing new variants. Study: No evidence of ...
Abnormally high levels of lung-injury biomarkers in the blood after COVID-19 infection may flag patients at risk for ongoing lung disease, an Imperial College London–led study suggests.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results